Related Experiment Video

Updated: Apr 29, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

6.5K

Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth

Kimberly H Kim1, Charles W M Roberts1

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematology/Oncology, Children's Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and Massachusetts Institute of Technology, Boston, MA, USA.

Cancer Genetics
|May 24, 2014
PubMed

Insights

SMARCB1, a key component of the SWI/SNF complex, is frequently lost in rhabdoid tumors and other cancers. Its inactivation drives tumor formation, highlighting its role as a tumor suppressor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SMARCB1 (INI1/SNF5/BAF47) is a core subunit of the SWI/SNF (BAF) chromatin-remodeling complex.
  • Inactivation of SMARCB1 is a hallmark of rhabdoid tumors, and germline mutations cause rhabdoid predisposition syndrome.
  • The SWI/SNF complex is frequently mutated in various human cancers, affecting approximately 20% of all cases.

Purpose of the Study:

  • To review the normal functions of SMARCB1 and the SWI/SNF complex.
  • To discuss the mechanisms by which SMARCB1 mutations contribute to cancer development.
  • To explore potential therapeutic strategies for SWI/SNF-mutant cancers.

Main Methods:

  • Literature review and synthesis of existing research on SMARCB1 and SWI/SNF complex.
  • Analysis of data from mouse models demonstrating Smarcb1's tumor suppressor role.
  • Discussion of genetic mutations identified in cancer patients.

Main Results:

  • Smarcbl inactivation in mouse models leads to rapid and 100% cancer development, confirming its tumor suppressor function.
  • SMARCB1 was the first identified mutated subunit of the SWI/SNF complex in cancer.
  • At least seven other SWI/SNF subunit genes are recurrently mutated across diverse human cancers.

Conclusions:

  • SMARCB1 inactivation is a critical driver in rhabdoid tumors and potentially other SWI/SNF-mutant cancers.
  • Understanding SMARCB1's function provides insights into a broad spectrum of human malignancies.
  • Further research into SWI/SNF complex mutations may reveal novel therapeutic targets.
Keywords:
Rhabdoid tumorSMARCB1SNF5SWI/SNFchromatin-remodeling complex

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

8.4K
Cell Population Analyses During Skin Carcinogenesis06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

15.5K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.9K